Georgia Cancer Specialists

Recent papers from Georgia Cancer Specialists

1. Young Male With Multifocal Oral UlcersJAMA Otolaryngology–Head & Neck Surgery · 2026
2. WF-1801: Single Arm Pilot Study of Ramipril for Prevention of Radiation-Induced Cognitive Decline in Glioblastoma Patients Receiving ChemoradiotherapyNeuro-Oncology Practice · 2026
3. A Case of Pityriasis Lichenoides Chronica Successfully Treated With UpadacitinibCase Reports in Dermatological Medicine · 2026
4. Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of boneFrontiers in Oncology · 2026
5. Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapyThe Oncologist · 2025
6. Abstract B102: Recruiting underrepresented patients via centralized navigation in a decentralized registry studyCancer Epidemiology Biomarkers & Prevention · 2025
7. ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer.Journal of Clinical Oncology · 2024
8. Enfortumab vedotin (EV) in non-squamous and squamous non–small cell lung cancer (NSCLC) cohorts of EV-202.Journal of Clinical Oncology · 2024
9. Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab TherapyCureus · 2024
10. Clinical Validation of a Machine-Learned, Point-of-Care System to IDENTIFY Functionally Significant Coronary Artery DiseaseDiagnostics · 2024
11. Advancing Precision-Targeted Treatment for Patients With Metastatic Non–Small Cell Lung CancerJournal of the Advanced Practitioner in Oncology · 2024
12. Addressing disparities in cancer clinical trials: a roadmap to more equitable accrualFrontiers in Health Services · 2024
13. Clinical Outcomes at Month 6 after Initiation of Cabotegravir and Rilpivirine Long-Acting (CAB + RPV LA) in an Observational Real-World Study (BEYOND)Open Forum Infectious Diseases · 2023
14. Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapyBlood · 2023
15. Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndromeJournal of Comparative Effectiveness Research · 2023
16. Hyperthermic intrathoracic extracorporeal chemotherapy for secondary malignant pleural diseaseJournal of Surgical Oncology · 2023
17. Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 WeeksOpen Forum Infectious Diseases · 2023
18. Water, sanitation, and hygiene access in Senegal and its impact on the occurrence of diarrhea in children under 5 years oldJournal of Water and Health · 2022
19. Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile InfectionJournal of Clinical Microbiology · 2022
20. Antibodies in Serum and MENSA Predict Non-recurrence in Primary Clostridioides difficile infection2021